Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1244]
News [2385]
Articles [91]
Editorials [4]
Conferences [117]
elearning [25]
Latest concepts in frontline therapy for paediatric ALL
Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA
Latest concepts in frontline therapy for paediatric ALL ( Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA )
23 Jan 2020
Endocrine toxicities of immunotherapy
Dr Ricky Frazer - Velindre Cancer Centre, Cardiff, Wales
Endocrine toxicities of immunotherapy ( Dr Ricky Frazer - Velindre Cancer Centre, Cardiff, Wales )
13 Jan 2020
Recognising sepsis in cancer patients
Dr Ron Daniels - Sepsis Trust, Birmingham, UK
Recognising sepsis in cancer patients ( Dr Ron Daniels - Sepsis Trust, Birmingham, UK )
13 Jan 2020
Endocrine dysfunction in patients receiving immunotherapy
Sherwin Criseno - University Hospitals Birmingham, Birmingham, UK
Endocrine dysfunction in patients receiving immunotherapy ( Sherwin Criseno - University Hospitals Birmingham, Birmingham, UK )
13 Jan 2020
Discussing the treatment of head and neck tumours in India
Dr Prateek Jain - Tata Medical Center, Kolkata, India
Discussing the treatment of head and neck tumours in India ( Dr Prateek Jain - Tata Medical Center, Kolkata, India )
10 Jan 2020
Is enasidenib plus azacitidine better than with azacitidine alone for AML...
Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA
Is enasidenib plus azacitidine better than with azacitidine alone for AML patients? ( Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA )
24 Dec 2019
PET-Directed therapy for early-stage diffuse large B-cell lymphoma
Prof Daniel Persky - University of Arizona Cancer Center, Tucson, USA
PET-Directed therapy for early-stage diffuse large B-cell lymphoma ( Prof Daniel Persky - University of Arizona Cancer Center, Tucson, USA )
24 Dec 2019
Dasatinib vs imatinib in the treatment of paediatric ALL
Dr Shuhong Shen - National Children's Medical Center, Shanghai, China
Dasatinib vs imatinib in the treatment of paediatric ALL ( Dr Shuhong Shen - National Children's Medical Center, Shanghai, China )
24 Dec 2019
Long-term outcomes of subjects with EBV driven PTLD following solid organ or...
Dr Sarah Nikiforow - Dana-Farber Cancer Institute, Boston, USA
Long-term outcomes of subjects with EBV driven PTLD following solid organ or allogeneic HCT treated with tabelecleucel ( Dr Sarah Nikiforow - Dana-Farber Cancer Institute, Boston, USA )
19 Dec 2019
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive...
Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
19 Dec 2019
The emerging role of immunotherapy for the treatment of early and advanced...
Dr Rita Nanda - UChicago Medicine, Chicago, USA
The emerging role of immunotherapy for the treatment of early and advanced breast cancer ( Dr Rita Nanda - UChicago Medicine, Chicago, USA )
18 Dec 2019
Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma
Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey, New Brunswick, USA
Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma ( Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey, New Brunswick, USA )
12 Dec 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation